Clinical Trials Logo

Filter by:
  • Withdrawn  
  • Page [1] ·  Next »
NCT ID: NCT03698045 Withdrawn - Clinical trials for Conjunctivitis, Bacterial

Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers.

PRO-143
Start date: November 2013
Phase: Phase 1
Study type: Interventional

Study to evaluate the safety and tolerability of PRO-143 solution ophthalmic in healthy volunteers.

NCT ID: NCT03417037 Withdrawn - Lung Cancer Clinical Trials

An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer

Start date: May 24, 2018
Phase: Phase 3
Study type: Interventional

This is a study of experimental medication BMS-986205 given with Nivolumab with or without chemotherapy compared to chemotherapy in participants with previously untreated stage IV or recurrent non-small cell lung cancer.

NCT ID: NCT02174094 Withdrawn - Dravet Syndrome Clinical Trials

Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

Start date: March 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the effect on the frequency of tonic-clonic and clonic seizures of clobazam as adjunctive therapy compared to placebo after 16 weeks of treatment in paediatric patients aged ≥1 to ≤16 years with Dravet Syndrome.

NCT ID: NCT02153424 Withdrawn - Clinical trials for Non-valvular Atrial Fibrillation (NVAF)

Early Post-marketing Study of Eliquis (Apixaban)

Start date: April 2014
Phase: N/A
Study type: Observational

The primary objective of the study is to identify and describe any suspected (AEs) in all patients with NVAF treated with Apixaban, as a request of the National Center of Pharmacovigilance (CNFV) in Mexico.

NCT ID: NCT02080130 Withdrawn - Gastroenteritis Clinical Trials

Efficacy of Two Probiotic Preparations in Children With Acute Diarrhoea

Start date: February 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine which of two different preparations of probiotics is effective in the treatment of acute viral diarrhoea in children.

NCT ID: NCT01967251 Withdrawn - Clinical trials for Erectile Dysfunction

Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction

Start date: September 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy, dose-response and safety of udenafil 25 mg, 50 mg and 75 mg every day (q.d.) for 12 weeks in the treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH and for the treatment of erectile dysfunction (ED).

NCT ID: NCT01870284 Withdrawn - Clinical trials for Spondylitis, Ankylosing

Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS)

SPIRIT A1
Start date: July 2014
Phase: Phase 3
Study type: Interventional

This study will assess the safety and efficacy of ixekizumab (LY2439821) compared to placebo in participants with active AS.

NCT ID: NCT01829009 Withdrawn - Sarcopenia Clinical Trials

Resistance Exercise Effect on Physical Performance and Functional Status in Sarcopenic Older Women

Start date: n/a
Phase: N/A
Study type: Interventional

Aging is characterized by a progressive loss of multiple physical and cognitive abilities. From these changes, the most important one is the loss of muscle mass, which has been called "sarcopenia". Resistance exercise is a therapeutic approach for sarcopenia, nevertheless there is no universal consensus. Therefore, this research is interested in determining the effect of a resistance exercise program on physical performance and/or functional status in sarcopenic older women. The main study hypothesis is that a program of resistance exercise will improve physical performance and functional status in sarcopenic older women compared against general recommendations. This is a single-blind, controlled clinical trial, including women> 70 years, living in the community with sarcopenia. Those who agree to participate, will be randomly assigned to one of the following groups: 1. Resistance Exercise Group 2. General Recommendations Group (control) The study will last 24 weeks, with 4 measurements performed at baseline, week 6, 12 and 24. Multilevel models (random effects) will be constructed for the comparison between the two groups. Tests will be conducted with a P=0.05 and confidence intervals at 95%. This protocol has been approved by the local ethics committee.

NCT ID: NCT01819623 Withdrawn - Clinical trials for Mild Cognitive Impairment

Effect of Non-pharmacological Therapy on Cognitive Function of Patients With Cognitive Impairment

Start date: n/a
Phase: N/A
Study type: Interventional

Supervised nonpharmacologic therapy improve cognitive function in patients with Mild Cognitive Impairment

NCT ID: NCT01744639 Withdrawn - Liver Carcinoma Clinical Trials

Analysis of Body Composition in Patients With Hepatocellular Carcinoma in Radioablation

Start date: December 2012
Phase: N/A
Study type: Interventional

Number of shows: 20 patients Track: A month with three visiting Intervention: Nutritional assessment including anthropometry, bioelectrical impedance, biochemical tests, Psychometric Hepatic Encephalopathy Score and Critical Flicker Frequency.